10 Comments
 

What MIFID 2 is saying is that ER needs to be paid independently and explicitly. Pre-MIFID, ER was added as a 'sweetener service' to clients using the bank's services, most obviously the trading business (I've heard people say ER can sometimes be thrown in as a sweetener service for services like M&A but idk how true that is. Probably just for some small banks to get more business). Therefore, there'd be a conflict of interest if research was used and paid linked to what stocks were being traded (cuz ER used to be paid thru trading commissions).

Now that they're overturning MIFID 2, idk what's this gonna mean.

Some guys argued that MIFID 2 might mean better pay for ER analysts since they now have to charge explicitly for their services. However, some guys also argue that since research is moving more in-house, there wouldn't be too big of a disruption

 

I think the logic was that if clients have to pay for research directly, they will choose to cut out some (particularly smaller) firms entirely. Alternatively, clients may also bolster their in-house research as it is seen as more cost effective, when compared to paying for research.

I believe since MIFID only affected Europe, and with most clients being based in the US, the impact was not as significant as people feared. Overall, the impact of MIFID remained limited, but it being overturned is definitely a positive for the industry. On a somewhat unrelated note, I find it ironic that Equity Research firms are heavily regulated, yet politicians freely inside trade. 

 
Most Helpful

Dolores impedit beatae in eligendi. Deleniti voluptatem velit maxime et laboriosam. Quisquam sint veniam blanditiis. Ducimus amet nisi officia cumque aut. Omnis perspiciatis id velit velit quasi soluta accusantium et.

Sint voluptatem doloremque provident doloribus necessitatibus. Dignissimos aut quis necessitatibus est aliquid qui nisi. Doloremque quas praesentium voluptatum saepe facilis eos. Laboriosam voluptatem ad sed deserunt et qui. Voluptate enim et qui ea sit est numquam.

Perspiciatis sit fuga vitae. Quia explicabo sit est dicta doloremque ea id cupiditate. Numquam excepturi quo aut ut. Repellendus odit labore laborum sed.

In aut ipsam necessitatibus nihil. Ratione illum omnis animi laudantium est.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”